Literature DB >> 8546851

Neuropsychiatric features of Lewy body disease.

C M Filley1.   

Abstract

Although traditionally associated with Parkinson's disease, the eosinophilic intracytoplasmic neuronal inclusion known as the Lewy body has recently been regarded as the primary neuropathologic finding in a variety of conditions affecting the aging brain. The term Lewy Body Disease (LBD) will be used in this review to refer to a spectrum of clinical states varying from those due to incidental or mildly symptomatic histopathologic changes to progressive dementia and psychosis. Many unanswered questions remain about the neurobehavioral and neuropathological implications of Lewy bodies, but it is useful to consider the LBD spectrum in terms of the variable effects on neuropsychiatric function that can be observed clinically.

Entities:  

Mesh:

Year:  1995        PMID: 8546851     DOI: 10.1006/brcg.1995.1254

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  5 in total

Review 1.  Diffuse Lewy body disease: clinical, pathological, and neuropsychological review.

Authors:  C A Luis; W Mittenberg; C S Gass; R Duara
Journal:  Neuropsychol Rev       Date:  1999-09       Impact factor: 7.444

Review 2.  Presenile dementia syndromes: an update on taxonomy and diagnosis.

Authors:  M D Greicius; M D Geschwind; B L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 3.  Posterior cortical atrophy: a brief review.

Authors:  Howard S Kirshner; Patrick J M Lavin
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

Review 4.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

Review 5.  Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease.

Authors:  Gregory A Jicha; Sarah A Carr
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.